AzTrials
AzTrials

Preterm BirthROOTNCT07559773

The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health

A study of Preterm Birth and Preeclampsia, run by GrowBaby Life Project.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

The 'Standard of Care Plus' ('PLUS') model in the ROOT Study consists of analyzing select micronutrient and gene variants of pregnant females to construct trimester-specific and personalized nutrition and lifestyle recommendations in collaboration with in-person standard obstetric care (SOC). Read more about this study

Who is it for?
Ages 18 years and older, women only
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
No sites listed yet
Study dates
Aug 2026to Dec 2033
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Pregnant women receiving care at NH Triad OB/GYN
  • ≤20 weeks gestational age at enrollment
  • Age ≥ 18 years (<18 years requires parental consent)
  • Ability to provide informed consent
  • Access to smart phone/internet for digital platform use

Who cannot join

  • > 20 weeks gestational age
  • High-risk pregnancies requiring specialized care beyond study scope
  • Inability to participate in digital health platform
  • Cognitive impairment preventing informed consent

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Leslie P Stone, MD contact

541-301-8446

lstonemd@gmail.com

Emily S Rydbom, MS contact

541-840-1503

emilyrydbom@yahoo.com

About this study

Official title: The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Integrated Model to Optimize Maternal and Infant Health: a Prospective Interventional Study: Resilient Outcomes Through OB-Nutrition Team Care (ROOT)

The 'Standard of Care Plus' ('PLUS') model in the ROOT Study consists of analyzing select micronutrient and gene variants of pregnant females to construct trimester-specific and personalized nutrition and lifestyle recommendations in collaboration with in-person standard obstetric care (SOC).

In 2014, the investigators demonstrated statistically significant reductions in adverse maternal and infant outcomes using the 'PLUS' model compared to SOC alone. Further study in a 50% Medicaid Oregon 'PLUS' cohort (N=387) demonstrated association with highly significant risk reductions in all primary outcomes (p-value <0.001): preterm birth: relative risk (RR) = 0.238 (4.2x less likely), hypertensive disorders of pregnancy: RR = 0.229 (4.4x less likely), gestational diabetes: RR = 0.071 (14x less likely), small for gestational age: RR = 0.252 (4x less likely), and large for gestational age: RR = 0.357 (2.8x less likely). A 100% Medicaid and ethnically diverse Nevada 'PLUS' cohort showed similar trends in all outcomes that were not statistically significant because of small sample size.

Read more

Structured as a prospective interventional study, the study evaluates whether the 'PLUS' model can achieve similar outcome improvements within the Novant Health (NH) system in North Carolina. The study will assess both clinical outcomes and digital nutrition platform performance within the existing healthcare infrastructure.

The primary hypothesis of the ROOT study is that collaborative implementation of the 'PLUS' nutritional care model at NH Triad Obstetrics/Gynecology (OB/GYN) Clinic will be associated with reduced maternal and infant adverse outcome rates when compared to historical regional and NH system outcomes in those who received SOC alone.

The secondary hypothesis of the ROOT Study is that the 'PLUS' model applied during pregnancy will be associated with reduced pediatric adverse outcomes. The 'PLUS' offspring that remain in the NH system will be observed longitudinally over 5 years with chart review at birth through 2 weeks of age, and at 1, 3, and 5 years of life. The outcomes assessed include neonatal intensive care unit (NICU) admission in the first two weeks of life, atopic dermatitis, eczema, asthma, allergies, otitis media, obesity, and autism. The 'PLUS' adverse outcome rates will be compared to adverse outcome rates in children born regionally and nationally under SOC alone.

Participant compliance with the 'PLUS' model, and participant and nutritionist access to the digital health platform will be studied during each trimester of use, as well as in the postpartum time period. The exploratory hypothesis is that the digital platform will not affect access, compliance, and rates of maternal and neonatal adverse outcomes.

Read the detailed description

Over a consecutive 2-year period, all pregnant females >17 years old presenting to Novant Health (NH) Triad Obstetrics/Gynecology (OB/GYN) at <20 weeks' gestation will be offered the cost-free virtual digital nutrition platform standard of care 'Plus' ('PLUS') model in addition to the in-person standard of care (SOC) routinely provided at the clinic. The 'PLUS' model will be offered to all eligible females regardless of payor source. After instruction and consent by 'PLUS'-trained clinic personnel, each participant will be on-boarded via a digital nutrition and health intake. Based on health information disclosed by the participant, body weight and height collected by the clinic, and select micronutrient and genomic evaluation, customized nutrition and lifestyle education and recommendations will be created through the digital nutrition platform with direct oversight by a 'PLUS'-trained board-certified nutrition professional. Virtual contact time allotment for the participant with the nutritionist is 60 minutes per trimester for customization of the nutrition and lifestyle plan, with unlimited text or digital follow-up.

The 'PLUS' diet is based on a pregnancy-adapted Mediterranean Diet modified by a low glycemic index with a 40% carbohydrate / 30% fat / 30% protein ratio that is seasonally, geographically, and socio-economically sensitive. Macronutrients will be calculated, and adjustments to the core food plan will be made each trimester based on nationally accepted pregnancy-specific Mifflin St. Jeor standards, with further refinement based on pre-pregnancy body mass index (BMI), gestational weight gain, activity, and dietary preferences.

Nutrition education will be personalized by trimester-specific physiologic demand, and by select gene variant analysis and micronutrient analysis. Gene variant analysis will include 42 gene variants used in the prior study associated with adverse maternal and neonatal outcomes, and non-communicable disease risk in the offspring. Micronutrient analysis will occur at intake, at each subsequent trimester, and at postpartum. It will include a complete blood count, serum zinc, carnitine (total and free), vitamin D (25(OH)D), ferritin, homocysteine, ionized calcium, vitamin B12, folate, glycosylated hemoglobin, and a lipid panel (total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides).

Sleep quality, movement, exogenous stress and mood will be assessed at intake, at 24-28 weeks gestation, and at 6-8 weeks postpartum. Other common pregnancy-related concerns will be addressed at each visit.

'PLUS' participants will receive a multi-nutrient prenatal supplement and iron separate from the multivitamin, a probiotic, and an Omega 3 fatty acid supplement or its vegan algal oil alternative. Because protein intake commonly remains insufficient, a protein supplement will be added. Collagen is selected because of its tolerability and ease of intake. Vitamin D3, acetyl l-carnitine, choline, and myo-inositol supplementation will occur if identified needs cannot be met with diet/lifestyle modification and base nutrient support alone. Other identified micronutrient insufficiencies will be managed with nutrient-rich food incorporation in the diet.

All participant-facing materials are created at 8th grade reading level and will be translated into Spanish, as needed. Nutrition and lifestyle communication will be transferred through the digital health platform which is Health Insurance Portability and Accountability Act (HIPAA) \& Systems and Organization Controls 2 (SOC2) compliant. Clinic staff will receive a 30-minute virtual training and an in-clinic logistical visit. Further OB provider communication regarding intervention changes, clinical condition, or persistent nutrient insufficiencies obtained through real-time chart review by the board-certified MD investigator will occur via secure e-mail to the OB provider or designee.

Consent for pediatric longitudinal follow-up of neonatal participants under the 'PLUS' model will occur at maternal participant intake. All neonatal participants remaining in the Novant Health system will be followed by chart review at 2 weeks for neonatal intensive care admission, and at 1, 3, and 5 years of life for occurrence of atopic dermatitis and eczema, asthma and allergy, otitis media, obesity, and autism spectrum disorder.

The investigators will examine the usability of the digital nutrition and lifestyle health platform that interfaces with NH Triad OB/GYN's electronic medical record to accomplish collaborative virtual personalized nutrition and lifestyle evaluation, education, and recommendations. The outcomes assessed will include participant and nutritionist access, compliance, and user experience during each trimester of use, and during the postpartum time period. Additionally, the investigators will evaluate the cost-efficiency of the 'PLUS' model compared to standard of care alone within the NH system by comparing frequency of and assigned reimbursement for the adverse maternal, neonatal, and childhood diagnoses and ICD-10 codes under study.

Being tested
'Standard of Care PLUS'
Keywords
adverse pregnancy outcomes, prevention, personalized nutrition, nutrigenomics, adverse neonatal outcomes, childhood asthma, childhood allergy, autism, childhood obesity, recurrent otitis media
Medical subject headings
Premature Birth, Pre-Eclampsia, Diabetes, Gestational, Dermatitis, Atopic, Autistic Disorder, Obesity, Pediatric Obesity, Otitis Media

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 'Standard of Care PLUS'Other

    Also called 'PLUS'

    All pregnant patients presenting to the sponsoring clinic will receive standard obstetric care. Those patients who meet inclusion criteria and agree to participate will receive standard obstetric care 'PLUS' select micronutrient and gene variant evaluation allowing creation of customized nutrition and lifestyle plans with targeted micronutrient supplementation. The plans will be modified in each trimester and postpartum to meet the physiologic demands specific to the time period. Serum micronutrient levels, nutrition/lifestyle plan adherence, and micronutrient supplementation adherence will be re-evaluated in each subsequent trimester and in the postpartum time period allowing individual adjustment. The 'PLUS' model will be delivered virtually via a digital nutrition health platform.

Study groups in NCT07559773
Study groupRoleWhat they receive
'Standard of Care Plus' ('PLUS')OtherThe 'Standard of care Plus' ('PLUS') model arm provides targeted nutritional and lifestyle interventions based on select gene variant and micronutrient analysis collaboratively with standard obstetric care. The comparators are historical regional and national standard obstetric care control groups.
Receives: Other: 'Standard of Care PLUS'

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preterm birth

    Preterm birth defined as delivery < 37 weeks gestation, further analysis stratified by delivery < 28 weeks, 28 to < 32 weeks, 32 to < 36 weeks, and 36 to < 37 weeks gestation per American College of Obstetricians and Gynecologists (ACOG) guidelines.

    Measured: The time period of study will be up to 31 weeks, beginning with entry into the study between 6 weeks gestation up to 19 6/7 weeks gestation, and will be completed at preterm birth or 36 6/7 weeks gestation.

Secondary outcomes (4)
  1. Hypertensive disorders of pregnancy (HDP)

    Hypertensive disorders of pregnancy (HDP) including gestational hypertension, preeclampsia, and eclampsia, diagnosis per ACOG guidelines.

    Measured: The time period of study will be up to 44 weeks, beginning at study entry between 6 weeks gestation up to 19 6/7 weeks gestation, and will be measured at time of diagnosis up to 6 weeks postpartum.

  2. Gestational Diabetes Mellitus (GDM)

    GDM defined by ACOG guidelines

    Measured: The time period of study will be up to 36 weeks, beginning at study entry between 6 weeks gestation up to 19 6/7 weeks gestation, and will be measured at time of diagnosis during gestation.

  3. Small for gestational age (SGA)

    SGA neonates defined as < 10th percentile weight per gestational age at birth using Fenton criteria, based on American Academy of Pediatrics (AAP) standards.

    Measured: At time of birth

  4. Large for Gestational Age (LGA)

    LGA defined as > 10th percentile weight per gestational age at birth based on Fenton criteria, per AAP standards.

    Measured: At time of birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2026
  2. Study startAug 2026 (estimated)
  3. Primary completionDec 2028 (estimated)
  4. Study completionDec 2033 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
All patients presenting to Novant Health Triad OB/GYN Clinic who are pregnant at less than 20 weeks gestation will be consented for participation in the study. Comparators will be historical, regional and national.
Masking
None (open label)
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07559773
Sponsor's protocol ID
The ROOT Study
Acronym
ROOT
Status last verified
Apr 2026
First submitted
11 Apr 2026
Last updated
30 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No individual participant data will be shared. At completion of the study all the data will be de-identified and grouped for purposes of analysis and publication.

Publications

  • Stone LP, Rydbom ES, Stone PM, Kim D. A 'Standard of Care PLUS' Model for Preterm Birth Prevention: Integrating Nutrient and Gene Variant Analysis with Targeted Interventions. J Pers Med. 2026 Feb 28;16(3):134. doi: 10.3390/jpm16030134.

    PubMed 41893003
  • Stone LP, Stone PM, Rydbom EA, Stone LA, Stone TE, Wilkens LE, Reynolds K. Customized nutritional enhancement for pregnant women appears to lower incidence of certain common maternal and neonatal complications: an observational study. Glob Adv Health Med. 2014 Nov;3(6):50-5. doi: 10.7453/gahmj.2014.053.

    PubMed 25568832

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in